Clotting factor activity in thawed Octaplas® LG during storage at 2–6°C for 6days from a quality assurance point of view
- 30 April 2012
- journal article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 46 (2) , 129-136
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Warfarin Reversal in Anticoagulant-Associated Intracerebral HemorrhageNeurocritical Care, 2008
- The Ratio of Blood Products Transfused Affects Mortality in Patients Receiving Massive Transfusions at a Combat Support HospitalJournal of Trauma: Injury, Infection & Critical Care, 2007
- ‘Blind’ transfusion of blood products in exsanguinating trauma patientsResuscitation, 2007
- Fresh Frozen Plasma Should be Given Earlier to Patients Requiring Massive Transfusion2007
- The Evidence-Based Use of FFP and Cryoprecipitate for Abnormalities of Coagulation Tests and Clinical CoagulopathyHematology-American Society Hematology Education Program, 2007
- Serious Hazards of Transfusion: A Decade of Hemovigilance in the UKTransfusion Medicine Reviews, 2006
- Timing of Fresh Frozen Plasma Administration and Rapid Correction of Coagulopathy in Warfarin-Related Intracerebral HemorrhageStroke, 2006
- Guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatantBritish Journal of Haematology, 2004
- Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusionThe Lancet, 2004
- Vitamin K‐dependent coagulation factors and fibrinogen levels in FFP remain stable upon repeated freezing and thawingTransfusion, 2003